REQUEST A DEMO
Total
USD $0.00
Search more companies

Ips Super Salud La Central S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Secondary Activities: Management of Companies and Enterprises | Other Ambulatory Health Care Services
Full name: Ips Super Salud La Central S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ips Super Salud La Central S.A.S. is an enterprise in Colombia, with the main office in Bucaramanga. It operates in the Diagnostic Imaging Centers industry. It was incorporated on June 04, 2020. The latest financial highlights indicate a net sales revenue increase of 169.43% in 2023. A growth of 111.9% was recorded in its total assets. The net profit margin of Ips Super Salud La Central S.A.S. decreased by 1.06% in 2023.

Headquarters
Via Palenque Cafe Madrid # 44 - 112
Bucaramanga; Santander;

Contact Details: Purchase the Ips Super Salud La Central S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Ips Super Salud La Central S.A.S. report to view the information.
Incorporation Date:
June 04, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ips Super Salud La Central S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
169.43%
Total operating revenue
169.43%
Operating profit (EBIT)
66.99%
Net Profit (Loss) for the Period
106.13%
Total assets
111.9%
Total equity
219.05%
Operating Profit Margin (ROS)
-9.25%
Net Profit Margin
-1.06%
Return on Equity (ROE)
-37.61%
Quick Ratio
0.24%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?